NeurologyLive Friday 5 — March 12, 2021

March 12, 2021
NeurologyLive Staff

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending March 12, 2021.

Welcome to NeurologyLive's Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive's widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.

1: Pediatric Neurological Exam to Identify SMA

Diana Castro, MD, walks through an in-person pediatric neurological exam and notes examination findings that may be identified in an infant with Spinal Muscular Atrophy (SMA), in this first episode of this Cure Connections series, "Cure SMA: Evaluation of SMA in the Era of Telehealth."

2: Mind Moments: The Pipeline Pendulum in Parkinson Disease

"Mind Moments," a podcast from NeurologyLive, brings you an exclusive interview with Stewart Factor, DO, about the therapeutic pipeline for Parkinson disease and some of the obstacles that stand in the way of providing optimal care to patients.

3: NeuroVoices: XinQi Dong, MD, MPH, on Assessing Evidence for Dementia Care Interventions

The director of the Institute for Health, Health Care Policy and Aging Research at Rutgers University discussed a recently published report on meeting the challenge of caring for persons with dementia and their care partners and caregivers.

4: The Changing Neuroinflammatory Response in Progressive MS: Benjamin Segal, MD

The chair of the Department of Neurology and the director of the Neuroscience Research Institute at The Ohio State University offered his insight on discontinuing treatment in progressive MS and the differences between progressive and relapsing disease.

5: The Obstacle of Discrimination in Alzheimer Care: Carl V. Hill, PhD, MPH

The chief diversity, equity, and inclusion officer at the Alzheimer’s Association discussed the findings of the association’s special edition of its annual Facts and Figures report.

In Case You Missed It: Coverage of the virtual Americas Committee for Treatment and Research in Multiple Sclerosis Forum 2021 is still ongoing! To check back in to see the latest data presentations and interviews with investigators and opinion leaders, and more, click here.